AI Portfolio Summary
In 2025 Q4, PERCEPTIVE ADVISORS LLC maintained a portfolio of 131 distinct positions. The most significant new addition to the portfolio was SPDR SERIES TRUST, which now represents 2.39% of the total fund value. They heavily accumulated shares in PRAXIS PRECISION MED, increasing their position by 27.6%. Conversely, PERCEPTIVE ADVISORS LLC completely exited their position in RHYTHM PHARMACEUTICA.
Total Positions
131
Quarter
2025 Q4
Top Holding
PRAX (10.5%)
Top 10 Concentration
41.8%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 131
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
PRAX
PRAXIS PRECISIO...
|
Healthcare | 10.49% | 2.39% |
#1
12
Prev: #13
|
8.5 | 431,432 | 27.6% |
P
S
|
1,995,986 | $588,296,914 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CELC
CELCUITY INC
|
Healthcare | 5.62% | 4.22% |
#2
2
Prev: #4
|
5.7 | 203,881 | 6.9% |
P
S
|
3,160,200 | $315,198,348 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RYTM
RHYTHM PHARMACE...
|
Healthcare | 4.86% | 8.33% |
#3
2
Prev: #1
|
2.9 | -416,558,578 | -99.4% |
P
S
|
2,546,391 | $272,565,693 | 2017 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ASND
ASCENDIS PHARMA...
|
Healthcare | 4.11% | 6.25% |
#4
2
Prev: #2
|
2.6 | -7,080 | -0.7% |
P
S
|
1,081,421 | $230,602,214 | 2015 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
APGE
APOGEE THERAPEU...
|
Healthcare | 3.14% | 1.55% |
#5
18
Prev: #23
|
4.8 | 978,662 | 72.4% |
P
S
|
2,330,651 | $175,917,537 | 2023 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ROIV
ROIVANT SCIENCE...
|
Healthcare | 3.09% | 3.22% |
#6
2
Prev: #8
|
3.2 | 617,000 | 8.4% |
P
S
|
7,985,461 | $173,284,504 | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NUVL
NUVALENT INC
|
Healthcare | 2.99% | 3.90% |
#7
2
Prev: #5
|
3.2 | 102,769 | 6.6% |
P
S
|
1,665,105 | $167,492,912 | 2021 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TVTX
TRAVERE THERAPE...
|
Healthcare | 2.91% | 2.62% |
#8
3
Prev: #11
|
3.2 | 483,565 | 12.7% |
P
S
|
4,278,180 | $163,469,258 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
XBI
PUT
SPDR SERIES TRU...
|
PUT Option | 2.39% | — |
#9
Prev: #—
|
4.5 | 1,100,000 | no change |
NEW
|
1,100,000 | $134,123,000 | 2015 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
EXAS
EXACT SCIENCES ...
|
Healthcare | 2.17% | 0.74% |
#10
29
Prev: #39
|
3.9 | 735,000 | 157.9% |
P
S
|
1,200,487 | $121,921,460 | 2010 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PTGX
PROTAGONIST THE...
|
Healthcare | 2.10% | 1.98% |
#11
6
Prev: #17
|
3.3 | 320,291 | 31.1% |
P
S
|
1,350,425 | $117,946,120 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
INBX
INHIBRX BIOSCIE...
|
Healthcare | 2.05% | 1.29% |
#12
15
Prev: #27
|
2.8 | 125,000 | 9.4% |
P
S
|
1,452,707 | $114,763,853 | 2021 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
EWTX
EDGEWISE THERAP...
|
Healthcare | 1.97% | 1.78% |
#13
6
Prev: #19
|
2.8 | 662,080 | 17.4% |
P
S
|
4,457,974 | $110,624,625 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IMTX
IMMATICS N.V
|
Healthcare | 1.94% | 2.31% |
#14
Prev: #14
|
2.8 | 1,000,000 | 10.7% |
P
S
|
10,383,456 | $109,026,288 | 2020 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SYRE
SPYRE THERAPEUT...
|
Healthcare | 1.79% | 0.60% |
#15
30
Prev: #45
|
3.7 | 1,839,780 | 149.6% |
P
S
|
3,069,225 | $100,547,811 | 2023 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AMLX
AMYLYX PHARMACE...
|
Healthcare | 1.78% | 3.51% |
#16
9
Prev: #7
|
1.2 | -667,483 | -7.5% |
P
S
|
8,284,882 | $100,081,375 | 2022 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ACLX
ARCELLX INC
|
Healthcare | 1.70% | 5.85% |
#17
14
Prev: #3
|
0.7 | -1,002,282 | -40.6% |
P
S
|
1,466,071 | $95,587,829 | 2022 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VRDN
VIRIDIAN THERAP...
|
Healthcare | 1.69% | 0.91% |
#18
15
Prev: #33
|
3.7 | 1,580,303 | 108.1% |
P
S
|
3,042,703 | $94,688,917 | 2021 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BSX
BOSTON SCIENTIF...
|
Healthcare | 1.66% | 0.87% |
#19
16
Prev: #35
|
3.7 | 669,000 | 215.8% |
P
S
|
979,000 | $93,347,650 | 2004 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
FOLD
AMICUS THERAPEU...
|
Healthcare | 1.62% | 1.45% |
#20
5
Prev: #25
|
1.6 | no change | no change |
P
S
|
6,370,851 | $90,720,918 | 2007 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ZYME
ZYMEWORKS INC
|
Healthcare | 1.53% | 1.03% |
#21
8
Prev: #29
|
3.6 | 1,171,187 | 56.0% |
P
S
|
3,261,850 | $85,884,511 | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ATXS
ASTRIA THERAPEU...
|
Healthcare | 1.51% | 1.36% |
#22
4
Prev: #26
|
1.6 | no change | no change |
P
S
|
6,485,420 | $84,894,147 | 2021 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MGTX
MEIRAGTX HLDGS ...
|
Healthcare | 1.46% | 3.00% |
#23
14
Prev: #9
|
1.1 | -2,300,000 | -18.2% |
P
S
|
10,326,103 | $82,092,519 | 2018 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AORT
ARTIVION INC
|
Healthcare | 1.40% | 2.47% |
#24
12
Prev: #12
|
1.1 | -297,710 | -14.7% |
P
S
|
1,722,290 | $78,553,647 | 2016 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CNTA
CENTESSA PHARMA...
|
Healthcare | 1.30% | 2.17% |
#25
10
Prev: #15
|
1.0 | -183,268 | -5.9% |
P
S
|
2,917,634 | $72,970,026 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DYN
DYNE THERAPEUTI...
|
Healthcare | 1.21% | 0.20% |
#26
42
Prev: #68
|
3.5 | 2,938,500 | 543.7% |
P
S
|
3,478,944 | $68,048,145 | 2020 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NRIX
NURIX THERAPEUT...
|
Healthcare | 1.20% | 0.38% |
#27
24
Prev: #51
|
3.5 | 2,139,728 | 151.1% |
P
S
|
3,555,877 | $67,454,987 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SLDB
SOLID BIOSCIENC...
|
Healthcare | 1.19% | 2.11% |
#28
12
Prev: #16
|
1.5 | no change | no change |
P
S
|
11,833,539 | $66,741,160 | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BLTE
BELITE BIO INC
|
Healthcare | 1.18% | 0.11% |
#29
46
Prev: #75
|
3.5 | 364,451 | 732.0% |
P
S
|
414,239 | $66,261,670 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ABVX
ABIVAX SA
|
Healthcare | 1.10% | 0.95% |
#30
2
Prev: #32
|
2.4 | 69,735 | 17.9% |
P
S
|
458,343 | $61,809,845 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IVVD
INVIVYD INC
|
Healthcare | 0.96% | — |
#31
Prev: #—
|
3.9 | 21,785,166 | no change |
NEW
|
21,785,166 | $53,809,360 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ENGN
ENGENE HOLDINGS...
|
Healthcare | 0.94% | 0.41% |
#32
17
Prev: #49
|
3.4 | 3,771,840 | 179.8% |
P
S
|
5,869,076 | $52,997,756 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RGEN
REPLIGEN CORP
|
Healthcare | 0.92% | 1.04% |
#33
5
Prev: #28
|
2.4 | 45,113 | 16.7% |
P
S
|
315,541 | $51,704,548 | 2002 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IMVT
IMMUNOVANT INC
|
Healthcare | 0.90% | 0.74% |
#34
4
Prev: #38
|
2.9 | 407,000 | 25.6% |
P
S
|
1,994,890 | $50,710,104 | 2020 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ISRG
INTUITIVE SURGI...
|
Healthcare | 0.89% | 0.67% |
#35
7
Prev: #42
|
3.4 | 35,800 | 68.7% |
P
S
|
87,919 | $49,793,805 | 2005 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SION
SIONNA THERAPEU...
|
Healthcare | 0.86% | 1.00% |
#36
6
Prev: #30
|
1.3 | no change | no change |
P
S
|
1,179,098 | $48,508,092 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NBIX
NEUROCRINE BIOS...
|
Healthcare | 0.84% | 1.82% |
#37
19
Prev: #18
|
0.3 | -119,000 | -26.4% |
P
S
|
331,050 | $46,952,821 | 2006 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DHR
DANAHER CORPORA...
|
Healthcare | 0.82% | — |
#38
Prev: #—
|
3.8 | 200,000 | no change |
NEW
|
200,000 | $45,784,000 | 2015 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ORKA
ORUKA THERAPEUT...
|
Healthcare | 0.80% | 0.70% |
#39
2
Prev: #41
|
2.3 | 208,480 | 16.4% |
P
S
|
1,476,501 | $44,752,745 | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CTMX
CYTOMX THERAPEU...
|
Healthcare | 0.74% | 0.89% |
#40
6
Prev: #34
|
1.3 | no change | no change |
P
S
|
9,680,185 | $41,237,588 | 2015 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
OMDA
OMADA HEALTH IN...
|
Healthcare | 0.67% | 1.53% |
#41
17
Prev: #24
|
1.3 | no change | no change |
P
S
|
2,396,330 | $37,814,087 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CDTX
CIDARA THERAPEU...
|
Healthcare | 0.65% | — |
#42
Prev: #—
|
3.8 | 165,131 | no change |
NEW
|
165,131 | $36,475,787 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IRON
DISC MEDICINE I...
|
Healthcare | 0.64% | — |
#43
Prev: #—
|
3.8 | 450,743 | no change |
NEW
|
450,743 | $35,793,502 | 2023 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DRUG
BRIGHT MINDS BI...
|
Healthcare | 0.62% | 0.79% |
#44
7
Prev: #37
|
1.2 | no change | no change |
P
S
|
449,290 | $35,062,592 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PEN
PENUMBRA INC
|
Healthcare | 0.61% | 1.61% |
#45
24
Prev: #21
|
0.2 | -110,018 | -49.9% |
P
S
|
110,529 | $34,364,571 | 2018 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ANRO
ALTO NEUROSCIEN...
|
Healthcare | 0.57% | 0.02% |
#46
42
Prev: #88
|
3.2 | 1,629,027 | 1048.5% |
P
S
|
1,784,393 | $31,762,195 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CAI
CARIS LIFE SCIE...
|
Healthcare | 0.55% | 0.96% |
#47
16
Prev: #31
|
0.7 | 38,043 | 3.5% |
P
S
|
1,136,206 | $30,654,838 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
JAZZ
JAZZ PHARMACEUT...
|
Healthcare | 0.52% | — |
#48
Prev: #—
|
3.7 | 170,000 | no change |
NEW
|
170,000 | $28,900,000 | 2012 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PALI
PALISADE BIO IN...
|
Healthcare | 0.50% | — |
#49
Prev: #—
|
3.7 | 12,050,000 | no change |
NEW
|
12,050,000 | $28,317,500 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RAPT
RAPT THERAPEUTI...
|
Healthcare | 0.50% | 0.14% |
#50
23
Prev: #73
|
3.2 | 642,000 | 349.1% |
P
S
|
825,890 | $27,972,894 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-50 of 131 holdings